Cytrx reported $1.29M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Brainstorm Cell Therapeutics BCLI:US USD 6.84M 750K
Celldex Therapeutics CLDX:US USD 28.1M 8.46M
Curis CRIS:US USD 15.43M 2.02M
Cytrx CYTR:US USD 1.29M 7.73M
Glaxosmithkline GSK:US GBP 5.51B 1.13B
Johnson & Johnson JNJ:US USD 19.51B 1.54B
Karyopharm Therapeutics KPTI:US USD 66.98M 15.6M
Northwest Biotherapeutics NWBO:US USD 16.28M 5.41M
Novartis NVS:US USD 11.05B 378M
Roche Holding ROG:VX 20.75B 3.26B
Seattle Genetics SGEN:US USD 703.1M 72.49M
Takeda 4502:JP JPY 949.56B 51.69B